Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

2.

Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.

Stewart EJ, Payne DE, Ma TM, VanEpps JS, Boles BR, Younger JG, Solomon MJ.

Appl Environ Microbiol. 2017 May 31;83(12). pii: e03483-16. doi: 10.1128/AEM.03483-16. Print 2017 Jun 15.

PMID:
28411222
3.

Fatal persistent methicillin-resistant Staphylococcus aureus bacteremia and vascular graft infections complicated with the formation of multiple abscesses despite aggressive medical therapy.

Shiba M, Yanai M, Maeda H, Shiono M.

SAGE Open Med Case Rep. 2015 Jun 12;3:2050313X15591314. doi: 10.1177/2050313X15591314. eCollection 2015.

4.

High frequency of methicillin-resistant Staphylococcus aureus in Peshawar Region of Pakistan.

Ullah A, Qasim M, Rahman H, Khan J, Haroon M, Muhammad N, Khan A, Muhammad N.

Springerplus. 2016 May 11;5:600. doi: 10.1186/s40064-016-2277-3. eCollection 2016.

5.

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China.

Lesher B, Gao X, Chen Y, Liu Z.

Clinicoecon Outcomes Res. 2016 Mar 24;8:63-72. doi: 10.2147/CEOR.S91985. eCollection 2016. Review.

6.

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr.

Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14. Review.

7.

Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.

Bhan U, Podsiad AB, Kovach MA, Ballinger MN, Keshamouni V, Standiford TJ.

PLoS One. 2015 Jan 30;10(1):e0114574. doi: 10.1371/journal.pone.0114574. eCollection 2015.

8.

Treatment of Gram-positive infections in critically ill patients.

Vazquez-Guillamet C, Kollef MH.

BMC Infect Dis. 2014 Nov 28;14:92. doi: 10.1186/1471-2334-14-92. Review.

9.

Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study.

Song Y, Yang Y, Chen W, Liu W, Wang K, Li X, Wang K, Papadimitropoulos M, Montgomery W.

Clinicoecon Outcomes Res. 2014 Oct 17;6:451-61. doi: 10.2147/CEOR.S65900. eCollection 2014.

10.

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.

Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C.

Infect Drug Resist. 2014 Oct 24;7:273-80. doi: 10.2147/IDR.S68658. eCollection 2014.

11.

Community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia without evidence of antecedent viral upper respiratory infection.

Toro CM, Janvier J, Zhang K, Fonseca K, Gregson D, Church D, Laupland K, Rabin H, Elsayed S, Conly J.

Can J Infect Dis Med Microbiol. 2014 May;25(3):e76-82.

12.

Ventilator-associated pneumonia.

Charles MP, Kali A, Easow JM, Joseph NM, Ravishankar M, Srinivasan S, Kumar S, Umadevi S.

Australas Med J. 2014 Aug 31;7(8):334-44. doi: 10.4066/AMJ.2014.2105. eCollection 2014. Review.

13.

Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia.

Chen C, Fan H, Huang Y, Peng F, Fan H, Yuan S, Tong Y.

Biomed Res Int. 2014;2014:602185. doi: 10.1155/2014/602185. Epub 2014 Jul 16.

14.

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Patel DA, Shorr AF, Chastre J, Niederman M, Simor A, Stephens JM, Charbonneau C, Gao X, Nathwani D.

Crit Care. 2014 Jul 22;18(4):R157. doi: 10.1186/cc13996.

15.

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study.

Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA; IMPACT-HAP Study Group.

Crit Care. 2014 Jun 10;18(3):R118. doi: 10.1186/cc13914.

16.

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Maschmeyer G, CarratalĂ  J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2015 Jan;26(1):21-33. doi: 10.1093/annonc/mdu192. Epub 2014 May 15.

18.

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.

Kalil AC, Klompas M, Haynatzki G, Rupp ME.

BMJ Open. 2013 Oct 14;3(10):e003912. doi: 10.1136/bmjopen-2013-003912.

19.

Aspiration pneumonia after stroke: intervention and prevention.

Armstrong JR, Mosher BD.

Neurohospitalist. 2011 Apr;1(2):85-93. doi: 10.1177/1941875210395775.

20.

Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

Diep BA, Afasizheva A, Le HN, Kajikawa O, Matute-Bello G, Tkaczyk C, Sellman B, Badiou C, Lina G, Chambers HF.

J Infect Dis. 2013 Jul;208(1):75-82. doi: 10.1093/infdis/jit129. Epub 2013 Mar 26.

Supplemental Content

Support Center